Cubist Systematic Strategies, LLC Johnson & Johnson Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

A detailed history of Cubist Systematic Strategies, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 15,200 shares of JNJ stock, worth $2.35 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

15,200

Previous 22,800 33.33%

Holding current value

$2.35 Million

Previous $3.33 Million 26.08%

% of portfolio

0.02%

Previous 0.02%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$155.22 - $162.74 $31.5 Million - $33 Million	202,930 Added 2693.17%	210,465 $33.3 Million
Q4 2023 Feb 14, 2024	SELL	$145.6 - $158.88 $7.76 Million - $8.47 Million	-53,324 Reduced 87.62%	7,535 $1.18 Million
Q3 2023 Nov 14, 2023	BUY	$155.75 - $174.48 $9.03 Million - $10.1 Million	57,959 Added 1998.59%	60,859 $9.48 Million
Q2 2023 Aug 14, 2023	SELL	$154.35 - $166.11 $6.75 Million - $7.26 Million	-43,727 Reduced 93.78%	2,900 $480,000
Q1 2023 May 15, 2023	BUY	$151.05 - $180.26 $3.6 Million - $4.29 Million	23,824 Added 104.48%	46,627 $7.23 Million
Q4 2022 Feb 14, 2023	SELL	$160.2 - $179.79 $1.56 Million - $1.75 Million	-9,733 Reduced 29.91%	22,803 $4.03 Million
Q3 2022 Nov 14, 2022	SELL	$161.33 - $179.52 $6.46 Million - $7.19 Million	-40,045 Reduced 55.17%	32,536 $5.32 Million
Q2 2022 Aug 15, 2022	BUY	$168.19 - $186.01 $2.87 Million - $3.17 Million	17,048 Added 30.7%	72,581 $12.9 Million
Q1 2022 May 16, 2022	SELL	$158.14 - $179.59 $438,838 - $498,362	-2,775 Reduced 4.76%	55,533 $9.84 Million
Q4 2021 Feb 14, 2022	SELL	$155.93 - $173.01 $5.54 Million - $6.14 Million	-35,511 Reduced 37.85%	58,308 $9.98 Million
Q3 2021 Nov 15, 2021	SELL	$161.5 - $179.47 $6.75 Million - $7.51 Million	-41,824 Reduced 30.83%	93,819 $15.2 Million
Q2 2021 Aug 16, 2021	BUY	$159.48 - $171.07 $9.35 Million - $10 Million	58,603 Added 76.07%	135,643 $22.3 Million
Q1 2021 May 17, 2021	BUY	$153.07 - $170.48 $10.5 Million - $11.6 Million	68,322 Added 783.69%	77,040 $12.7 Million
Q4 2020 Feb 16, 2021	SELL	$137.11 - $157.38 $6.8 Million - $7.8 Million	-49,587 Reduced 85.05%	8,718 $1.37 Million
Q3 2020 Nov 16, 2020	SELL	$140.38 - $153.83 $13.2 Million - $14.4 Million	-93,770 Reduced 61.66%	58,305 $8.68 Million
Q2 2020 Aug 14, 2020	BUY	$128.81 - $155.51 $7.73 Million - $9.34 Million	60,038 Added 65.23%	152,075 $21.4 Million
Q1 2020 May 15, 2020	BUY	$111.14 - $153.99 $9.05 Million - $12.5 Million	81,449 Added 769.26%	92,037 $12.1 Million
Q4 2019 Feb 14, 2020	SELL	$127.5 - $146.44 $21.8 Million - $25 Million	-170,914 Reduced 94.17%	10,588 $1.54 Million
Q3 2019 Nov 14, 2019	SELL	$126.95 - $142.14 $3.22 Million - $3.61 Million	-25,403 Reduced 12.28%	181,502 $23.5 Million
Q2 2019 Aug 14, 2019	BUY	$131.15 - $144.24 $22.3 Million - $24.5 Million	170,030 Added 461.1%	206,905 $28.8 Million
Q1 2019 May 15, 2019	BUY	$125.72 - $139.79 $3.97 Million - $4.42 Million	31,617 Added 601.31%	36,875 $5.16 Million
Q4 2018 Feb 14, 2019	SELL	$122.84 - $147.84 $9.19 Million - $11.1 Million	-74,824 Reduced 93.43%	5,258 $679,000
Q3 2018 Nov 14, 2018	BUY	$121.58 - $142.88 $2.15 Million - $2.53 Million	17,693 Added 28.36%	80,082 $11.1 Million
Q2 2018 Aug 14, 2018	BUY	$119.4 - $131.76 $5.68 Million - $6.27 Million	47,589 Added 321.55%	62,389 $7.57 Million
Q1 2018 May 15, 2018	SELL	$125.1 - $148.14 $731,209 - $865,878	-5,845 Reduced 28.31%	14,800 $1.9 Million
Q4 2017 Feb 14, 2018	SELL	$131.22 - $143.62 $3.58 Million - $3.92 Million	-27,304 Reduced 56.94%	20,645 $2.89 Million
Q3 2017 Nov 14, 2017	BUY	$129.47 - $135.38 $6.21 Million - $6.49 Million	47,949	47,949 $6.23 Million

Others Institutions Holding JNJ

# of Institutions

4,272

Shares Held

1.68B

Call Options Held

17.6M

Put Options Held

14.5M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $404B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account

Cubist Systematic Strategies, LLC Johnson & Johnson Transaction History